DEF 14A
DEFINITIVE PROXY 2011
- Company
- ABVC BIOPHARMA, INC.
- Filed
- January 20, 2011
- Period of Report
- January 20, 2011
- Accession Number
- 0001173313-11-000010
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →